Danaher Corporation $DHR Shares Acquired by Capital World Investors

Capital World Investors lifted its stake in shares of Danaher Corporation (NYSE:DHR) by 0.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 492,865 shares of the conglomerate’s stock after purchasing an additional 3,856 shares during the quarter. Capital World Investors’ holdings in Danaher were worth $112,827,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in DHR. Norges Bank acquired a new stake in shares of Danaher during the 4th quarter worth approximately $2,177,106,000. Viking Global Investors LP raised its position in shares of Danaher by 543.9% during the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after purchasing an additional 2,455,994 shares during the period. Massachusetts Financial Services Co. MA raised its position in shares of Danaher by 104.7% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock worth $991,923,000 after purchasing an additional 2,216,789 shares during the period. Generation Investment Management LLP raised its position in shares of Danaher by 34.0% during the 3rd quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock worth $1,319,354,000 after purchasing an additional 1,689,020 shares during the period. Finally, Capital International Investors raised its position in shares of Danaher by 8.9% during the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after purchasing an additional 1,487,768 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of DHR stock opened at $183.47 on Tuesday. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The firm has a market capitalization of $129.85 billion, a price-to-earnings ratio of 35.49, a price-to-earnings-growth ratio of 2.46 and a beta of 0.81. The business has a 50 day simple moving average of $181.19 and a 200 day simple moving average of $205.80. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same period in the prior year, the company posted $1.88 EPS. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. On average, equities research analysts anticipate that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is 30.95%.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. JPMorgan Chase & Co. dropped their price target on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Wells Fargo & Company dropped their price target on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 22nd. Robert W. Baird dropped their price target on Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a research report on Friday, April 17th. Citigroup started coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. Finally, HSBC decreased their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $235.14.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.